Currently Reading
Medication Adherence as it Relates to Quality of Diabetes Care
September 05, 2013
Healthcare Reform and Patient-Centered Diabetes Care
August 29, 2013
Session 2: Discussant
August 28, 2013
Session 2: Discussant
August 12, 2013
Session 1: Discussant
July 31, 2013
Session 1: Discussant
July 25, 2013
Glycemic Targeting
July 25, 2013
Therapeutic Choice and Outcomes at the Physician Level
July 23, 2013
Keynote
July 19, 2013

Medication Adherence as it Relates to Quality of Diabetes Care

Josh Benner, PharmD, ScD
Josh Benner, PharmD, ScD, says nonadherence in diabetes medication is a large contributor to high costs in healthcare and should be a priority for care givers.
Josh Benner, PharmD, ScD, says nonadherence in diabetes medication is a large contributor to high costs in healthcare, and should be a priority for care givers. Macrotrends in both policy and practice may change this problem. One such trend is the growing amount of evidence linking adherence to clinical outcomes and costs. That evidence can then work its way into the development of quality measures. Another example of a macrotrend is the drive for meaningful use of electronic health records.

“As frustrated as many of us are that we're not improving adherence widely, the truth is that it's not because we don't know how,” says Dr Benner. “Many people used to think of this as pharma's problem or as patients' problem, but now it's payers problem and it's providers' problem.  So we all share responsibility for making this better.”

Consensus-based quality measures, especially in the area of diabetes medication use, will continue to improve adherence rates and reduce costs on the health system.



 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!